Quotient Sciences Quotient Sciences

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Digital content for Cytokinetics

    Client Virtual Booth

    CYTOKINETICS

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Cytokinetics
    United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    280 East Grand Ave South San Francisco, CA 94115
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://cytokinetics.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/cytokinetics
    Twitter
    Twitter
    https://twitter.com/Cytokinetics

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    Cytokinetics Announces Late-Breaking Trial Presentations at ESC Congress
    Cytokinetics Announces Late-Breaking Trial Presentations at ESC Congress

    https://www.globenewswire.com/news-release/2024/04/10/2860658/35409/en/Cytokinetics-Announces-Three-Late-Breaking-Clinical-Trial-Presentations-Relating-to-SEQUOIA-HCM-at-the-European-Society-of-Cardiology-Heart-Failure-2024-Congress.html

    GLOBENEWSWIRE
    10 Apr 2024
    Share Share
    Cytokinetics Presents Additional 48-Week Data From FOREST-HCM at ACC
    Cytokinetics Presents Additional 48-Week Data From FOREST-HCM at ACC

    https://www.globenewswire.com/news-release/2024/04/05/2858458/35409/en/Cytokinetics-Presents-Additional-48-Week-Data-From-FOREST-HCM-the-Open-Label-Extension-Clinical-Study-of-Aficamten-at-The-American-College-of-Cardiology-73%CA%B3%E1%B5%88-Annual-Scientific-Sess.html

    GLOBENEWSWIRE
    05 Apr 2024
    Share Share
    Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    https://www.globenewswire.com/news-release/2024/04/02/2856449/35409/en/Cytokinetics-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    02 Apr 2024
    Share Share
    Cytokinetics to Participate in the 23rd Annual Healthcare Conference
    Cytokinetics to Participate in the 23rd Annual Healthcare Conference

    https://www.globenewswire.com/news-release/2024/04/01/2855405/35409/en/Cytokinetics-to-Participate-in-the-23rd-Annual-Needham-Virtual-Healthcare-Conference.html

    GLOBENEWSWIRE
    01 Apr 2024
    Share Share
    Cytokinetics Announces Four Upcoming Presentations at American C of Cardiology
    Cytokinetics Announces Four Upcoming Presentations at American C of Cardiology

    https://www.globenewswire.com/news-release/2024/03/25/2851599/35409/en/Cytokinetics-Announces-Four-Upcoming-Presentations-at-the-American-College-of-Cardiology-73rd-Annual-Scientific-Session.html

    GLOBENEWSWIRE
    25 Mar 2024
    Share Share
    Cytokinetics to Participate in March Investor Conferences
    Cytokinetics to Participate in March Investor Conferences

    https://www.globenewswire.com//news-release/2024/03/04/2839946/35409/en/Cytokinetics-to-Participate-in-March-Investor-Conferences.html

    GLOBENEWSWIRE
    04 Mar 2024
    Share Share
    Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    https://www.globenewswire.com//news-release/2024/03/01/2839053/35409/en/Cytokinetics-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    01 Mar 2024
    Share Share
    Cytokinetics not in sale process, CEO says
    Cytokinetics not in sale process, CEO says

    https://www.fiercebiotech.com/biotech/no-ongoing-sale-process-cytokinetics-ceo-says-following-novartis-acquisition-rumors#:~:text=No%20ongoing%20sale%20process%20at%20Cytokinetics%2C%20CEO%20says%20following%20Novartis%20acquisition%20rumors&text=After%20being%20the%20center%20of,will%20be%20acquiring%20the%20biotech.

    FIERCE BIOTECH
    28 Feb 2024
    Share Share
    Cytokinetics, The Mended Hearts, Inc. and WomenHeart Announce Launch of New Initiative to Increase Engagement in Cardiovascular Clinical Trials
    Cytokinetics, The Mended Hearts, Inc. and WomenHeart Announce Launch of New Initiative to Increase Engagement in Cardiovascular Clinical Trials

    https://www.globenewswire.com//news-release/2024/02/28/2836860/35409/en/Cytokinetics-The-Mended-Hearts-Inc-and-WomenHeart-Announce-Launch-of-New-Initiative-to-Increase-Engagement-in-Cardiovascular-Clinical-Trials.html

    GLOBENEWSWIRE
    28 Feb 2024
    Share Share
    Cytokinetics Reports Fourth Quarter 2023 Financial Results
    Cytokinetics Reports Fourth Quarter 2023 Financial Results

    https://www.globenewswire.com//news-release/2024/02/27/2836411/35409/en/Cytokinetics-Reports-Fourth-Quarter-2023-Financial-Results.html

    GLOBENEWSWIRE
    27 Feb 2024
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    polpharma-m-2024-04-15

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search